B-cell Chronic Lymphocytic Leukemia (B-CLL)
2 clinical trials · Condition
◉ Watch B-cell Chronic Lymphocytic Leukemia (B-CLL)
| Record | Firm | Date |
|---|---|---|
| Treatment With Bendamustine, Ofatumumab and MethylPrednisolone in Relapsed B-CLL (NCT01612988) | French Innovative Leukemia Organisation | 2012-07-01 |
| Subcutaneous Alemtuzumab (CAMPATH®, MabCampath®) in Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia (NCT00328198) | Genzyme, a Sanofi Company | 2006-05-01 |
Track B-cell Chronic Lymphocytic Leukemia (B-CLL) automatically
Every clearance here is in the API, with alerts when new ones post.